Mie Rizig

4.7k total citations
23 papers, 331 citations indexed

About

Mie Rizig is a scholar working on Neurology, Molecular Biology and Physiology. According to data from OpenAlex, Mie Rizig has authored 23 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Neurology, 10 papers in Molecular Biology and 7 papers in Physiology. Recurrent topics in Mie Rizig's work include Parkinson's Disease Mechanisms and Treatments (9 papers), Neurological disorders and treatments (5 papers) and Alzheimer's disease research and treatments (4 papers). Mie Rizig is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (9 papers), Neurological disorders and treatments (5 papers) and Alzheimer's disease research and treatments (4 papers). Mie Rizig collaborates with scholars based in United Kingdom, Nigeria and Egypt. Mie Rizig's co-authors include Andrew McQuillin, Hugh Gurling, Henry Houlden, Marketa Zvelebil, Andrew Harrison, Jacob Lawrence, Khalid Choudhury, Aylwin Ng, Michelle Robinson and Hugh Gurling and has published in prestigious journals such as The Lancet, Nature Medicine and PLoS ONE.

In The Last Decade

Mie Rizig

16 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mie Rizig United Kingdom 9 137 114 107 66 57 23 331
Ricardo Sáinz‐Fuertes United Kingdom 9 119 0.9× 52 0.5× 100 0.9× 65 1.0× 28 0.5× 18 318
Elizabeth L. Clore United States 5 232 1.7× 59 0.5× 45 0.4× 70 1.1× 79 1.4× 5 376
Adva Hadar Israel 9 175 1.3× 67 0.6× 48 0.4× 81 1.2× 14 0.2× 12 316
Avia Merenlender‐Wagner Israel 7 124 0.9× 69 0.6× 53 0.5× 66 1.0× 29 0.5× 8 404
Nelide Romeo Italy 11 89 0.6× 53 0.5× 115 1.1× 66 1.0× 97 1.7× 14 362
Huiyi Jiang China 11 167 1.2× 43 0.4× 40 0.4× 39 0.6× 38 0.7× 21 321
Tamar Chachua United States 12 130 0.9× 85 0.7× 177 1.7× 46 0.7× 32 0.6× 19 412
Martin Schäfer Germany 6 97 0.7× 44 0.4× 91 0.9× 40 0.6× 16 0.3× 10 272
R.B. Lu Taiwan 7 186 1.4× 59 0.5× 66 0.6× 41 0.6× 33 0.6× 12 377
Artemis Iatrou United States 10 329 2.4× 93 0.8× 35 0.3× 107 1.6× 43 0.8× 14 502

Countries citing papers authored by Mie Rizig

Since Specialization
Citations

This map shows the geographic impact of Mie Rizig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mie Rizig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mie Rizig more than expected).

Fields of papers citing papers by Mie Rizig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mie Rizig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mie Rizig. The network helps show where Mie Rizig may publish in the future.

Co-authorship network of co-authors of Mie Rizig

This figure shows the co-authorship network connecting the top 25 collaborators of Mie Rizig. A scholar is included among the top collaborators of Mie Rizig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mie Rizig. Mie Rizig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rizig, Mie, et al.. (2026). Genetic insights from Parkinson disease in African and African admixed populations. Nature Reviews Neurology. 22(2). 71–72.
2.
Rizig, Mie. (2025). The case for investing in global genomic medicine. Nature Medicine. 31(2). 366–366.
3.
Abbadessa, Gianmarco, A. Nagano, Simon Hametner, et al.. (2025). Mapping Molecular Pathways of Multiple Sclerosis: A Gene Prioritization and Network Analysis of White Matter Pathology Transcriptomics. Annals of Neurology. 98(1). 67–79.
4.
Ojo, Oluwadamilola O., Sara Bandrés‐Ciga, Mary B. Makarious, et al.. (2024). GBA 1 rs3115534 Is Associated with REM Sleep Behavior Disorder in Parkinson's Disease in Nigerians. Movement Disorders. 39(4). 728–733. 6 indexed citations
5.
Elsayed, Inas, Njideka Okubadejo, Richard Walker, et al.. (2024). Advancing Parkinson's Disease Research in Africa: A Strategic Training Framework of the Global Parkinson's Genetics Program. Movement Disorders. 40(1). 51–56. 1 indexed citations
6.
El-Jaafary, Shaimaa I, et al.. (2024). Metabolomic profiling reveals altered phenylalanine metabolism in Parkinson’s disease in an Egyptian cohort. Frontiers in Molecular Biosciences. 11. 1341950–1341950. 6 indexed citations
7.
8.
Fall, Maouly, Oluwadamilola O. Ojo, Njideka Okubadejo, et al.. (2024). An exploration of the genetics of the mutant Huntingtin (mHtt) gene in a cohort of patients with chorea from different ethnic groups in sub‐Saharan Africa. Annals of Human Genetics. 89(4). 149–157.
9.
Beetz, Christian, Peter Bauer, Petra Pavelekova, et al.. (2022). Prevalence of Fabry Disease among Patients with Parkinson’s Disease. Parkinson s Disease. 2022(1). 1014950–1014950. 3 indexed citations
10.
Fall, Maouly, et al.. (2022). Spectrum of movement disorders: Experience of a one and half year of existence of the first specialized center in Senegal. Parkinsonism & Related Disorders. 98. 13–15. 1 indexed citations
11.
Kaiyrzhanov, Rauan, Akbota Aitkulova, Chingiz Shashkin, et al.. (2020). LRRK2 Mutations and Asian Disease-Associated Variants in the First Parkinson’s Disease Cohort from Kazakhstan. Parkinson s Disease. 2020. 1–10. 7 indexed citations
12.
Houlden, Henry, et al.. (2020). Novel fluid biomarkers to differentiate frontotemporal dementia and dementia with Lewy bodies from Alzheimer's disease: A systematic review. Journal of the Neurological Sciences. 415. 116886–116886. 19 indexed citations
13.
Rizig, Mie, et al.. (2020). Comparing fluid biomarkers of Alzheimer's disease between African American or Black African and white groups: A systematic review and meta-analysis. Journal of the Neurological Sciences. 421. 117270–117270. 21 indexed citations
14.
Rizig, Mie, Oluwadamilola O. Ojo, Alkyoni Athanasiou‐Fragkouli, et al.. (2020). Negative screening for 12 rare LRRK2 pathogenic variants in a cohort of Nigerians with Parkinson's disease. Neurobiology of Aging. 99. 101.e15–101.e19. 4 indexed citations
15.
Okubadejo, Njideka, Mie Rizig, Oluwadamilola O. Ojo, et al.. (2018). Leucine rich repeat kinase 2 (LRRK2) GLY2019SER mutation is absent in a second cohort of Nigerian Africans with Parkinson disease. PLoS ONE. 13(12). e0207984–e0207984. 14 indexed citations
16.
Sharp, Sally I., Ying Hu, Mie Rizig, et al.. (2013). The effect of clozapine on mRNA expression for genes encoding G protein-coupled receptors and the protein components of clathrin-mediated endocytosis. Psychiatric Genetics. 23(4). 153–162. 11 indexed citations
17.
Rizig, Mie, Andrew McQuillin, Aylwin Ng, et al.. (2012). A gene expression and systems pathway analysis of the effects of clozapine compared to haloperidol in the mouse brain implicates susceptibility genes for schizophrenia. Journal of Psychopharmacology. 26(9). 1218–1230. 31 indexed citations
18.
Datta, Susmita, Andrew McQuillin, Mie Rizig, et al.. (2008). A threonine to isoleucine missense mutation in the pericentriolar material 1 gene is strongly associated with schizophrenia. Molecular Psychiatry. 15(6). 615–628. 45 indexed citations
19.
20.
Rizig, Mie, Andrew McQuillin, Vinay Puri, et al.. (2006). Failure to confirm genetic association between schizophrenia and markers on chromosome 1q23.3 in the region of the gene encoding the regulator of G‐protein signaling 4 protein (RGS4). American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 141B(3). 296–300. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ricardo Sáinz‐Fuertes Breakdown of academic impact, for papers by Elizabeth L. Clore Breakdown of academic impact, for papers by Adva Hadar Breakdown of academic impact, for papers by Avia Merenlender‐Wagner Breakdown of academic impact, for papers by Nelide Romeo Breakdown of academic impact, for papers by Huiyi Jiang Breakdown of academic impact, for papers by Tamar Chachua Breakdown of academic impact, for papers by Martin Schäfer Breakdown of academic impact, for papers by R.B. Lu Breakdown of academic impact, for papers by Artemis Iatrou
Rankless by CCL
2026